EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking‐Based Identification of Potential Natural Neuroprotective Molecules for Parkinson's Disease

Poonam Bhadauriya, Vibhav Varshney, Ahsas Goyal iD

Chemistry & Biodiversity · 2023-10 · 20 (10)

DOI: 10.1002/cbdv.202300979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 08.09.2023. Verfasst von Poonam Bhadauriya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Research, GLA University, Mathura, UP, India. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents, Molecular Docking Simulation, Flavonoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is a common progressive neurodegenerative and the prevailing treatments are ineffective in the early stages of the disease. Therefore, other strategies must be devised to halt the steady decrease of dopaminergic neurons in the brain. In Parkinson's disease, a dysregulated ACE/Ang II/AT1R axis in the brain causes free radical damage, apoptosis, and neuronal destruction. Current PD treatments only alleviate symptoms and do not reverse the degradation mechanism of dopaminergic neurons. As a result, it is critical to discover alternate, dependable medicines for the treatment of Parkinson's disease.

Method

In the present study, homology modelling of MAS receptor, in silico docking and molecular dynamic studies (MDS) were employed to determine the efficacy of flavonoids as MASR activators.

Result

The flavonoids Pterosupin and Amentoflavone exhibited best binding and therefore, the stability of these complexes were evaluated with MDS studies. The Pterosupin‐MASR complex demonstrated better stability, stronger interactions and minimal fluctuation than the Amentoflavone‐MASR complex.

Conclusion

The data from the present study indicated that the flavonoid Pterosupin possesses better binding, favourable pharmacokinetic properties and stability. However, subsequent in vitro and in vivo assessments are necessary to validate its efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeuroprotective AgentsMolecular Docking SimulationFlavonoidsBiological ProductsHumansReceptors, G-Protein-CoupledMolecular Dynamics SimulationMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

MASParkinson's diseaseamentoflavonenatural compoundsneurodegeneration

Substanzen

Neuroprotective AgentsFlavonoidsBiological ProductsReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Institute of Pharmaceutical Research, GLA University, Mathura, UP, India.
  • Institute of Professional Studies, College of Pharmacy, Gwalior, MP, India.

ORCID-Profile: Ahsas Goyal

Zitieren

APA

Bhadauriya, P., Varshney, V., & Goyal, A. (2023). Molecular Docking‐Based Identification of Potential Natural Neuroprotective Molecules for Parkinson's Disease. Chemistry & Biodiversity, 20(10). https://doi.org/10.1002/cbdv.202300979

Vancouver

Bhadauriya P, Varshney V, Goyal A. Molecular Docking‐Based Identification of Potential Natural Neuroprotective Molecules for Parkinson's Disease. Chemistry & Biodiversity. 2023;20(10). doi:10.1002/cbdv.202300979

BibTeX
@article{Bhadauriya2023,
  author = {Bhadauriya, Poonam and Varshney, Vibhav and Goyal, Ahsas},
  title = {Molecular Docking‐Based Identification of Potential Natural Neuroprotective Molecules for Parkinson's Disease},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  volume = {20},
  number = {10},
  doi = {10.1002/cbdv.202300979}
}
Kostenlos starten →